✦ LIBER ✦

Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease

✍ Scribed by Imbimbo, Bruno P; Ottonello, Simone; Frisardi, Vincenza; Solfrizzi, Vincenzo; Greco, Antonio; Seripa, Davide; Pilotto, Alberto; Panza, Francesco

Book ID: 120179335
Publisher: Expert Reviews
Year: 2012
Tongue: English
Weight: 887 KB
Volume: 8
Category: Article
ISSN: 1744-666X
DOI: 10.1586/eci.11.93

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 3 Trials of Solanezumab for Mild-t

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

✍ Doody, Rachelle S.; Thomas, Ronald G.; Farlow, Martin; Iwatsubo, Takeshi; Vellas 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 514 KB

Nicergoline in the Treatment of Mild- to

Nicergoline in the Treatment of Mild- to- Moderate Alzheimer's Disease

✍ Bengt Winblad, M. Luisa Bonura, Bianca M. Rossini, Dr Angelo Battaglia 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 241 KB

Rivastigmine transdermal system for the

Rivastigmine transdermal system for the treatment of mild to moderate Alzheimer’s disease

✍ G. T. Grossberg; C. Sadowsky; J. T. Olin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

Efficacy and Safety of Intravenous Solan

Efficacy and Safety of Intravenous Solanezumab in Patients with Mild to Moderate Alzheimer's Disease: Results of Two Phase 3 Studies

✍ Hake, Ann M.; Siemers, Eric; Carlson, Christopher; Estergard, Wahiba; Sundell, K 📂 Article 📅 2013 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 50 KB

Management of Mild to Moderate Alzheimer

Management of Mild to Moderate Alzheimer Disease

✍ Greg L. Plosker, Gillian M. Keating 📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 214 KB

Sleep disturbance in mild to moderate Al

Sleep disturbance in mild to moderate Alzheimer's disease

✍ Maria Moran; C.A. Lynch; C. Walsh; R. Coen; D. Coakley; B.A. Lawlor 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 102 KB